The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law BPC 157 and TB 500 are the two most paired peptides in injury research, and most people think they do the same thing. They don't. BPC 157 acts locally. It signals at the injury site, drives Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma